A new €4M European project brings a mobile insulin pump from France, computer models from Romania, and research from the UK & Spain together, in order to improve living with diabetes.
The project is named PEPPER and wants to empower the 42 million people suffering from type I diabetes to ‘self-manage’ their disease.
Self-management would allow patients to improve their lifestyle and prevent adverse episodes resulting from too high or too low blood sugar level.
Cellnovo is industry connection in this project, having been established in 2002. In 2015 it even held an IPO on the Euronext Paris, raising €31M.
While not as radical as some cyborg-like MedTech inventions, Cellnovo developed a mobile diabetes management system. This includes a a rechargeable pump that simulates a healthy pancreas –